Author: Biotech Metropolitan

Digital biotech company OccamzRazor recently raised $6.1MM in a series A funding round that closed in March 2022. The round was led by Jeff Dean, the head of Google AI, a division of Google dedicated to tackling healthcare problems and advancing scientific discovery by leveraging computer science. OccamzRazor is a biotech startup on a mission to cure brain aging through digital science. The company uses natural language processing, graph prediction, and graph machine learning to map out disease processes related to aging, such as Parkinson’s Disease. The company claims that human capacity is not sufficient to translate all the public…

Read More

According to the American Academy of Dermatology Association, one in five Americans will develop skin cancer in their lifetime. Skin cancer is one of the most common cancers that can affect anyone with any skin color. Risk to skin cancer comes from exposure to natural and artificial ultraviolet light, unprotected skin and experiencing sunburns. Mortality rates from skin cancer are largely from melanoma. 20 Americans die every day from melanoma. Mortality rates vary among females, males, and age groups. Research shows men with melanoma have lower survival rates than women in the same age group. The five-year survival rate for…

Read More

When a field that depends on scientific benchwork suddenly moves online, what happens to collaborations and the innovation supply chain? We are seeing the answer to this question play out in real time during the Covid-19 crisis. Across the United States and abroad, measures to safeguard against this serious […] Click here to view original web page at endpts.com

Read More

FILE – This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the Novel Coronavirus SARS-CoV-2. Also known as 2019-nCoV, the virus causes COVID-19. The sample was isolated from a patient in the U.S. On Tuesday, April 21, 2020, U.S. health […] Click here to view original web page at www.wivb.com

Read More

Biotech investors might have had an exciting year in 2019 with an impressive amount of new drug approvals. There were 14 notable bankruptcies last year as well, the highest since 2011. Although it’s less common to see a company declare bankruptcy in the biotech sector than in other industries, […] Click here to view original web page at newyork.citybizlist.com

Read More

NYU Langone Health’s new biotech incubator will support the translation of game-changing discoveries by scientists into new treatments for patients. (Sean Pavone/Shutterstock) NYU Langone Health opened a 50,000-square-foot biotech incubator space in Manhattan that has attracted backing from big-name corporate sponsors including biopharma giants Bristol-Myers Squibb, Sanofi and Boehringer […] Click here to view original web page at www.fiercehealthcare.com

Read More